Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Determinants of Glycemic Control: Phase 2 Analysis From Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (Nppcd-2018) Publisher Pubmed



Esteghamati A1 ; Ismailbeigi F2 ; Khaloo P1 ; Moosaie F1 ; Alemi H1 ; Mansournia MA3 ; Afarideh M1 ; Janbabaei Molla G4 ; Ghadimi T5 ; Shadnoush M6 ; Kermanchi J7 ; Ghaemi F8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Medicine, Biochemistry, Physiology and Biophysics, Division of Clinical and Molecular Endocrinology, Case Western Reserve University, Cleveland, OH, United States
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Deputy of Curative Affaires of Ministry of Health & Medical Education, Tehran, Iran
  5. 5. Department of Surgery, Iran Medical University, Tehran, Iran
  6. 6. Department of Clinical Nutrition, Shahid Beheshti University of Medical Science, Tehran, Iran
  7. 7. Disease Management Advisor-Curative Affair Deputy-Ministry of Health and Medical Education, Tehran, Iran
  8. 8. Department of Transplantation and Disease, Ministry of Health & Medical Education, Tehran, Iran

Source: Primary Care Diabetes Published:2020


Abstract

Background: Diabetes is one of the leading causes of morbidity and mortality worldwide, especially among middle and low income nations. Many diabetic complications and comorbidities are attributable to poor glycemic control. The aim of this study was to update and extend the national diabetes reports on the status of comorbidities, diabetes care and complications in Iran. Moreover, we investigated the risk factors of poor glycemic control in the Iranian population. Methods: National database of 99,651 patients with diabetes who attended university-affiliated clinics between April 1, 2017 and February 30, 2018 was used to carry out a cross-sectional study. Stepwise backward selection logistic regression model was used to examine the associated factors of glycemic control. Results: In this study 73.0% and 56.5% of the enrolled population with diabetes, had hypertension and hyperlipidemia, respectively. The prevalence of patients who received education for nutrition therapy or diabetes self-management was 16.3% and 23.3% respectively. Poor glycemic control was associated with male gender (OR = 1.06, p = 0.001), obesity (OR = 1.03, p = 0.05), duration of diabetes (OR = 1.018, p < 0.001), smoking (OR = 1.08, p = 0.041), hypertension (OR = 1.53, p < 0.001), hyperlipidemia (OR = 1.15, p < 0.001), insulin therapy (OR = 1.26, p < 0.001) and combination of insulin and oral anti-diabetic agents compared to oral anti-diabetic agents alone (OR = 2.36, p < 0.001). Conclusion: We demonstrated that the prevalence of diabetes comorbidities is high in Iranian population and that a great proportion of Iranian patients with diabetes had not reached the goal of glycemic control. Our findings provide a starting point from which to investigate the obstacles that prevent patients with diabetes from reaching metabolic targets. © 2019 Primary Care Diabetes Europe
Related Docs
View other Related Docs
1. Diabetes in Iran: Prospective Analysis From First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (Nppcd-2016), Scientific Reports (2017)
2. Quality of Care in Type 2 Diabetes in Iran; a Cross-Sectional Study Using Patient-Level Data, BMC Endocrine Disorders (2022)
3. Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran, Canadian Journal of Diabetes (2020)
4. Trends in Cardiovascular Risk Factors in Diabetic Patients in Comparison to General Population in Iran: Findings From National Surveys 2007–2016, Scientific Reports (2020)
5. Challenges to Lifestyle Medicine for Type 2 Diabetes in Iran: A Synoptic Review, American Journal of Lifestyle Medicine (2023)
6. Impact of 3-Year Changes in Lipid Parameters and Their Ratios on Incident Type 2 Diabetes: Tehran Lipid and Glucose Study, Nutrition and Metabolism (2018)
7. Iran Diabetes Research Roadmap (Idrr) Study; Analysis of Diabetes Comorbidity Studies in Iran: A Review Article, Iranian Journal of Public Health (2017)
8. Diabetes Care in Iran: Where We Stand and Where We Are Headed, Annals of Global Health (2015)
Experts (# of related papers)
View all Related Experts
Alireza Esteghamati (15)
Bagher Larijani (11)
Other Related Docs
9. The Diabetes Cascade of Care Through the 14 Years in Iran: Findings of Nationwide Steps Surveys 2007–2021, Journal of Diabetes and Metabolic Disorders (2023)
10. Prevalence of Diabetes and Prediabetes, and Achievements in Diabetes Control in Iran; the Results of the Steps of 2016, Archives of Iranian Medicine (2022)
11. Evaluation of the Diabetes Care Cascade and Compliance With Who Global Coverage Targets in Iran Based on Steps Survey 2021, Scientific Reports (2023)
12. Pharmacoeconomic Evaluation of Insulin Aspart and Glargine in Type 1 and 2 Diabetes Mellitus in Iran, Journal of Diabetes and Metabolic Disorders (2023)
13. Challenges to Lifestyle Medicine for Type 2 Diabetes in Iran: A Synoptic Review, American Journal of Lifestyle Medicine (2025)
14. A New Model for Optimization of Diabetes Clinics With the Case Study in Iran, Journal of Diabetes and Metabolic Disorders (2022)
15. Association of Preoperative Hemoglobin A1c With In-Hospital Mortality Following Valvular Heart Surgery, Brazilian Journal of Cardiovascular Surgery (2020)
16. Ottawa Charter Framework As a Guide for Type 2 Diabetes Prevention and Control in Iran, Journal of Diabetes and Metabolic Disorders (2019)
17. Early Insulin Glargine Initiation in Iranian People With Uncontrolled Type 2 Diabetes: Glycemic Control, and Adverse Events, Acta Medica Iranica (2018)
18. Burden of Type 1 Diabetes Mellitus in the North Africa and Middle East Region, 1990–2019; Findings From the Global Burden of Disease Study, Diabetes Research and Clinical Practice (2022)
19. Quality and Cost of Healthcare Services in Patients With Diabetes in Iran: Results of a Nationwide Short-Term Longitudinal Survey, Frontiers in Endocrinology (2023)
20. Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data From Persian Cohort Study, Diabetes Therapy (2021)
21. National Innovation System for Diabetes and Metabolic Disorders Can Promote Biomedical Research Accountability; a Literature Review and Designing a Conceptual Framework, Journal of Diabetes and Metabolic Disorders (2021)
22. Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 As Biomarkers for Diabetic Kidney Disease, Kidney and Blood Pressure Research (2020)
23. The External Validity and Performance of the No-Laboratory American Diabetes Association Screening Tool for Identifying Undiagnosed Type 2 Diabetes Among the Iranian Population, Primary Care Diabetes (2020)
24. Diabetes Mellitus and Its Risk Factors Among a Middle-Aged Population of Iran, a Population-Based Study, International Journal of Diabetes in Developing Countries (2016)
25. Beneficial Effects of Pentoxifylline Plus Losartan Dual Therapy in Type 2 Diabetes With Nephropathy, American Journal of the Medical Sciences (2018)
26. Inadequate Achievement of Abc Goals (Hba1c, Blood Pressure, Ldl-C) Among Patients With Type 2 Diabetes in an Iranian Population, 2012–2017, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2020)
27. Iran Diabetes Research Study; Knowledge Discovery in Diagnosis: A Scoping Review, Journal of Diabetes and Metabolic Disorders (2021)
28. Comparison of Primary Versus Secondary Prevention of Cardiovascular Disease in Patients With Type2 Diabetes: Focus on Achievement of Abc Goals, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2019)
29. Worldwide Trends in Diabetes Since 1980: A Pooled Analysis of 751 Population-Based Studies With 4.4 Million Participants, The Lancet (2016)
30. Evaluation of the Effect of Vitamin D Supplementation on Anthropometric Indicators and Dietary Intake of Patients With Type 2 Diabetes, Reports of Biochemistry and Molecular Biology (2021)
31. Long-Term Cost-Effectiveness of Quality of Diabetes Care; Experiences From Private and Public Diabetes Centers in Iran, Health Economics Review (2022)
32. Nutrient Sensing Pathway Genes Expression Dysregulated in Patients With T2dm and Coronary Artery Disease, Diabetes Research and Clinical Practice (2019)
33. Gabric Diabetes School: An Innovative Education Centre for People With Diabetes; [Gabric, L’Ecole Du Diabete: Un Centre D’Education Pour Diabetiques Innovant], Eastern Mediterranean Health Journal (2018)
34. Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross-Sectional Study, Endocrinology# Diabetes and Metabolism (2024)
35. Management Goal Achievements of Diabetes Care in Iran: Study Profile and Main Findings of Diacare Survey, Journal of Diabetes and Metabolic Disorders (2023)
36. Nut Consumption Is Associated With Lower Incidence of Type 2 Diabetes: The Tehran Lipid and Glucose Study, Diabetes and Metabolism (2017)
37. Genetic Variants in Long Noncoding Rna H19 and Meg3 Confer Risk of Type 2 Diabetes in an Iranian Population, Gene (2018)
38. Identifying Associations Between Health Services Operational Factors and Health Experience for Patients With Type 2 Diabetes in Iran, BMC Health Services Research (2021)
39. Effects of a Mediterranean Diet on the Development of Diabetic Complications: A Longitudinal Study From the Nationwide Diabetes Report of the National Program for Prevention and Control of Diabetes (Nppcd 2016-2020), Maturitas (2021)
40. The Trend of Risk for Cardiovascular Diseases During the Past Decade in Iran, Applying No-Lab and Lab-Based Prediction Models, Global Heart (2023)
41. Prevalence and Determinants of Diabetes and Prediabetes in Southwestern Iran: The Khuzestan Comprehensive Health Study (Kchs), BMC Endocrine Disorders (2021)
42. A Cost-Effectiveness Analysis of Risk-Based Intervention for Prevention of Cardiovascular Diseases in Irapen Program: A Modeling Study, Frontiers in Public Health (2023)
43. Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes Mellitus Among the Adult Residents of Tehran: Tehran Cohort Study, BMC Endocrine Disorders (2022)
44. Knowledge of Physicians Regarding the Management of Type Two Diabetes in a Primary Care Setting: The Impact of Online Continuous Medical Education, BMC Medical Education (2020)
45. Reasons for Non-Participation in a Self-Care Training Program for Diabetic Patients: A Qualitative Study, BMC Health Services Research (2022)
46. Impact of Educational Intervention Based on Interactive Approaches on Beliefs, Behavior, Hemoglobin A1c, and Quality of Life in Diabetic Women, International Journal of Preventive Medicine (2016)
47. Cardiovascular Events in People With Type 2 Diabetes: Performance of Framingham, Ukpds, and Advance Risk Equations, Acta Medica Iranica (2021)
48. Senior Dental Students’ Knowledge and Practice Regarding to Oral Health of Diabetic Patients in Tehran, Iran, Health Education and Health Promotion (2022)
49. Obesity and Diabetic Complications: A Study From the Nationwide Diabetes Report of the National Program for Prevention and Control of Diabetes (Nppcd-2021) Implications for Action on Multiple Scales, Primary Care Diabetes (2022)
50. Prevalence of Type 2 Diabetes Complications and Its Association With Diet Knowledge and Skills and Self-Care Barriers in Tabriz, Iran: A Cross-Sectional Study, Health Science Reports (2023)